Menu
Sign In Search Podcasts Charts People & Topics Add Podcast API Pricing
Podcast Image

DiversifyRx

Semaglutide Compounding Update: What 503A Pharmacies Need to Know | Becoming A Pharmacy Badass

24 Apr 2025

Description

**Dr. Lisa Faast shares an important update on the current status of Semaglutide Compounding as of April 23** **Show Notes:** 1. **Semaglutide Compounding Update for 503A Pharmacies** [0:00] 2. **Tirzepatide Compounding and Legal Considerations** [3:38] 3. **Practical Advice for Pharmacies** [6:36] 4. **Final Thoughts and Contact Information** [7:39] <br> **Links mentioned in this episode:** [FDA's decision on Semaglutide] (https://www.fda.gov/drugs/drug-safety-and-availability/fda-clarifies-policies-compounders-national-glp-1-supply-begins-stabilize) [OFA-Outsourcing Facilities Association] (https://www.503bs.org/) Websites Mentioned: https://www.olympiapharmacy.com/ https://www.drlisafaast.com/ ----- #### **Becoming a Badass Pharmacy Owner Podcast is a Proud to be Apart of the Pharmacy Podcast Network**

Audio
Featured in this Episode

No persons identified in this episode.

Transcription

This episode hasn't been transcribed yet

Help us prioritize this episode for transcription by upvoting it.

0 upvotes
🗳️ Sign in to Upvote

Popular episodes get transcribed faster

Comments

There are no comments yet.

Please log in to write the first comment.